SCHEMBL1403871

SCHEMBL1403871

Cc1nc2cc(C=CC#N)ccc2s1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
HSD17B10 Q99714 2/20 0.45
ALDH1A1 P00352 4/20 0.44
TP53 P04637 2/20 0.44
MAPT P10636 1/20 0.44
PKM P14618 1/20 0.44
HPGD P15428 1/20 0.44
GAA P10253 1/20 0.42
KMT2A Q03164 1/20 0.41
POLB P06746 1/20 0.40
KDM4E B2RXH2 1/20 0.39
ESR1 P03372 1/20 0.39
ENPP2 Q13822 1/20 0.39
FDPS P14324 1/20 0.38
LMNA P02545 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1403870 1.00 SMN1; SMN2 (0.45) SMN1; SMN2NPC1RAB9AHSD17B10ALDH1A1
SCHEMBL6268298 0.88 SMN1; SMN2 (0.49) SMN1; SMN2NPC1RAB9AHSD17B10ALDH1A1
SCHEMBL6268297 0.88 SMN1; SMN2 (0.49) SMN1; SMN2NPC1RAB9AHSD17B10ALDH1A1
SCHEMBL12810135 0.81 SMN1; SMN2 (0.50) SMN1; SMN2NPC1RAB9AHSD17B10ALDH1A1
SCHEMBL2092831 0.80 SMN1; SMN2 (0.49) SMN1; SMN2NPC1RAB9AHSD17B10ALDH1A1
SCHEMBL2092834 0.80 SMN1; SMN2 (0.49) SMN1; SMN2NPC1RAB9AHSD17B10ALDH1A1
SCHEMBL2056140 0.77 HSD17B10 (0.50) SMN1; SMN2NPC1RAB9AHSD17B10ALDH1A1
SCHEMBL2963197 0.76 SMN1; SMN2 (0.56) SMN1; SMN2NPC1RAB9AHSD17B10ALDH1A1
SCHEMBL31359169 0.76 ALDH1A1 (0.52) SMN1; SMN2NPC1RAB9AHSD17B10ALDH1A1
SCHEMBL30644079 0.76 SMN1; SMN2 (0.56) SMN1; SMN2NPC1RAB9AHSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2291351-A1 ALPHA-MERCAPTO-AMIDES Novartis AG (CH) 2011-03-09 EP disclosed
WO-2009135526-A1 ALPHA-MERCAPTO-AMIDES NOVARTIS AG (CH) 2009-11-12 WO disclosed